CNPY2 controls Macrophage Metabolic Programming and Epigenetic Remodeling 2305267

Abstract Introduction Understanding the metabolic—epigenetic axis in macrophages is critical for human health. In cancer, metabolic and epigenetic reprogramming in tumor-associated macrophages (TAMs) can drive tumor-promoting phenotypes, aiding immune evasion and therapy resistance. However, the regulators linking these processes remain unclear. We previously found that Canopy homolog 2 (CNPY2) promotes chemical hepatocarcinogenesis by regulating macrophage cytokine production, migration, phagocytosis, and cytotoxicity. CNPY2 binds TLR4 and enhances NF-κB—dependent cytokine production in liver macrophages, thereby promoting DEN-induced HCC. Methods To investigate whether CNPY2 influences macrophage immunometabolism and associated chromatin modifications, we generated Cnpy2 knockout mice and used a carcinogen-induced liver cancer mouse model, combining with RNA-seq analysis, qRT-PCR and Western blotting. Results RNA-seq analysis revealed distinct transcriptional changes in metabolic pathways, including de novo lipogenesis, Fatty acid oxidation, and the TCA cycle between wild-type (WT) and Cnpy2-knockout (KO) liver macrophages. Gene-set enrichment analysis further showed altered expression of epigenetic regulators and histone modifying enzymes in Cnpy2-deficient macrophages. We then performed qPCR on selecting metabolic genes, confirming alterations of several RNA-seq-identified targets. Consistent with these findings, protein levels of metabolic enzymes, particularly in acetyl-coA pathway, were significantly increased in Cnpy2 KO liver macrophages. In addition, global histone H3 acetylation was also elevated in Cnpy2 KO liver macrophages compared with WT counterparts. Conclusion Our data suggest that CNPY2 plays a previously unrecognized role in coordinating macrophage metabolic programming and epigenetic regulation. These findings provide an initial framework for understanding how CNPY2 may integrate metabolic cues with chromatin state to shape macrophage function. Funding Source NCI R01CA270166 Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1287
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CNPY2 controls Macrophage Metabolic Programming and Epigenetic Remodeling 2305267

Feng Hong, Shima Ebadollahibaruq, Lingbin Meng
The Journal of Immunology
Immune cells in cancer
article

CNPY2 controls Macrophage Metabolic Programming and Epigenetic Remodeling 2305267

Feng Hong, Shima Ebadollahibaruq, Lingbin Meng
article en

Abstract

Abstract Introduction Understanding the metabolic—epigenetic axis in macrophages is critical for human health. In cancer, metabolic and epigenetic reprogramming in tumor-associated macrophages (TAMs) can drive tumor-promoting phenotypes, aiding immune evasion and therapy resistance. However, the regulators linking these processes remain unclear. We previously found that Canopy homolog 2 (CNPY2) promotes chemical hepatocarcinogenesis by regulating macrophage cytokine production, migration, phagocytosis, and cytotoxicity. CNPY2 binds TLR4 and enhances NF-κB—dependent cytokine production in liver macrophages, thereby promoting DEN-induced HCC. Methods To investigate whether CNPY2 influences macrophage immunometabolism and associated chromatin modifications, we generated Cnpy2 knockout mice and used a carcinogen-induced liver cancer mouse model, combining with RNA-seq analysis, qRT-PCR and Western blotting. Results RNA-seq analysis revealed distinct transcriptional changes in metabolic pathways, including de novo lipogenesis, Fatty acid oxidation, and the TCA cycle between wild-type (WT) and Cnpy2-knockout (KO) liver macrophages. Gene-set enrichment analysis further showed altered expression of epigenetic regulators and histone modifying enzymes in Cnpy2-deficient macrophages. We then performed qPCR on selecting metabolic genes, confirming alterations of several RNA-seq-identified targets. Consistent with these findings, protein levels of metabolic enzymes, particularly in acetyl-coA pathway, were significantly increased in Cnpy2 KO liver macrophages. In addition, global histone H3 acetylation was also elevated in Cnpy2 KO liver macrophages compared with WT counterparts. Conclusion Our data suggest that CNPY2 plays a previously unrecognized role in coordinating macrophage metabolic programming and epigenetic regulation. These findings provide an initial framework for understanding how CNPY2 may integrate metabolic cues with chromatin state to shape macrophage function. Funding Source NCI R01CA270166 Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)

The Journal of ImmunologyVol. 215(Supplement_1)
The Ohio State University (US)
Partnerships for the goals
Openalex Percentile: Top 15%
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.